The Promise of Next Generation Sequencing for Infectious Disease Diagnostics
Conference Recording Sep 19, 2013
About the Speaker
Till Bachmann is Reader in Personalised Medicine in Infectious Diseases in the Division of Pathway Medicine, University of Edinburgh. His scientific interests focus on rapid molecular diagnostics of infectious diseases and antibiotic resistance targeting stratified medicines. Till has published extensively, is a named inventor on various patent applications, and he has led a number of large interdisciplinary diagnostic projects (e.g. ITI Techmedia Chronic Wound Care / Biosensing Platform Programme). Till is a founding member of the European Diagnostics Cluster Alliance; he sits on the Scientific Advisory Board of the Biomedical Diagnostics Institute and the Steering Group for the Biosensing Group of the Electronics, Sensors, Photonics KTN.
The adoption of molecular diagnostics of infectious diseases and antibiotic resistance is well on the rise, serving an ever increasing demand for rapid results which can be obtained at the point of care. The advent of next generation sequencing technologies is now set to revolutionise these applications in infectious disease diagnostics, outbreak tracking and personalised medicine.